Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    April 2021
  1. JACOBSON FL, Dezube AR, Bravo-Iniguez C, Kucukak S, et al
    Preserving NLST mortality benefits and acceptable morbidity for lung cancer surgery in a community hospital.
    J Surg Oncol. 2021 Apr 12. doi: 10.1002/jso.26483.
    PubMed     Abstract available


  2. BI W, Zhao S, Wu C, Gao J, et al
    Pulmonary mucosa-associated lymphoid tissue lymphoma: CT findings and pathological basis.
    J Surg Oncol. 2021;123:1336-1344.
    PubMed     Abstract available


    March 2021
  3. SONODA D, Matsuura Y, Kondo Y, Ichinose J, et al
    Comparison of local therapy in patients with lung oligo-recurrence of non-small-cell lung cancer.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26453.
    PubMed     Abstract available


  4. FELDMAN HA, Zhou N, Antonoff MB, Hofstetter WL, et al
    Simultaneous versus staged resections for bilateral pulmonary metastases.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26392.
    PubMed     Abstract available


  5. MONTENEGRO GB, Farid S, Liu SV
    Immunotherapy in lung cancer.
    J Surg Oncol. 2021;123:718-729.
    PubMed     Abstract available


  6. DUAN XQ, Wang XL, Zhang LF, Liu XZ, et al
    Establishment and validation of a prediction model for the probability of malignancy in solid solitary pulmonary nodules in northwest China.
    J Surg Oncol. 2021;123:1134-1143.
    PubMed     Abstract available


  7. VIDARSDOTTIR H, Siesing C, Nodin B, Jonsson P, et al
    Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors.
    J Surg Oncol. 2021;123:1144-1156.
    PubMed     Abstract available


    February 2021
  8. ZHOU C, Wang Y, Qian G, Li H, et al
    Clinical significance of indeterminate pulmonary nodules on the survival of 364 patients with nonmetastatic, high-grade, localized osteosarcoma: A 12-year retrospective cohort study.
    J Surg Oncol. 2021;123:587-595.
    PubMed     Abstract available


  9. BERTOGLIO P, Querzoli G, Ventura L, Aprile V, et al
    Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
    J Surg Oncol. 2021;123:560-569.
    PubMed     Abstract available


  10. CHEN J, Gu C, Chen X, Dai C, et al
    Clinicopathological and prognostic analyses of 86 resected pulmonary lymphoepithelioma-like carcinomas.
    J Surg Oncol. 2021;123:544-552.
    PubMed     Abstract available


    January 2021
  11. TSAI PC, Hsu PK, Yeh YC, Chen CK, et al
    Active surveillance or early resection for ground-glass nodules that need preoperative localization.
    J Surg Oncol. 2021;123:322-331.
    PubMed     Abstract available


    December 2020
  12. DOLAN DP, White A, Mazzola E, Lee DN, et al
    Outcomes of superior segmentectomy versus lower lobectomy for superior segment Stage I non-small-cell lung cancer are equivalent: An analysis of 196 patients at a single, high volume institution.
    J Surg Oncol. 2020 Dec 1. doi: 10.1002/jso.26304.
    PubMed     Abstract available


  13. WHITE AA, Lee DN, Mazzola E, Kucukak S, et al
    Adjuvant therapy following induction therapy and surgery improves survival in N2-positive non-small cell lung cancer.
    J Surg Oncol. 2020 Dec 1. doi: 10.1002/jso.26305.
    PubMed     Abstract available


  14. CLAXTON MR, Reynolds G, Wenger DE, Rose PS, et al
    Extraskeletal myxoid chondrosarcoma: A high incidence of metastatic disease to lymph nodes.
    J Surg Oncol. 2020;122:1662-1667.
    PubMed     Abstract available


    November 2020
  15. ZHA P, Deng HY
    Diabetes mellitus and prognosis of non-small-cell lung cancer patients after surgery: What do we know?
    J Surg Oncol. 2020 Nov 20. doi: 10.1002/jso.26307.
    PubMed    


  16. ZALEPUGAS D, Koryllos A, Stoelben E, Ludwig C, et al
    Sleeve lobectomy versus lobectomy for primary treatment of non-small-cell lung cancer: A single-center retrospective analysis.
    J Surg Oncol. 2020 Nov 6. doi: 10.1002/jso.26286.
    PubMed     Abstract available


  17. OZTURK A, Sener MU, Yilmaz A
    Bronchoscopic procedures during COVID-19 pandemic: Experiences in Turkey.
    J Surg Oncol. 2020;122:1020-1026.
    PubMed     Abstract available


    October 2020
  18. KASEDA K, Hishida T, Masai K, Asakura K, et al
    Clinicopathological and prognostic features of operable non-small cell lung cancer patients with diabetes mellitus.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26243.
    PubMed     Abstract available


  19. GOROSPE L, Ayala-Carbonero AM, Mirambeaux-Villalona RM, Benito-Berlinches A, et al
    Percutaneous imaging-guided biopsies in patients with COVID-19 positive cancer performed at the peak of the COVID-19 pandemic.
    J Surg Oncol. 2020;122:986-988.
    PubMed    


    September 2020
  20. LUTFI W, Martinez-Meehan D, Sultan I, Evans N 3rd, et al
    Racial disparities in local therapy for early stage non-small-cell lung cancer.
    J Surg Oncol. 2020 Sep 14. doi: 10.1002/jso.26206.
    PubMed     Abstract available


  21. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
    Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2020;122:523-528.
    PubMed     Abstract available


  22. COLLAUD S, Stork T, Schildhaus HU, Pottgen C, et al
    Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter.
    J Surg Oncol. 2020;122:506-514.
    PubMed     Abstract available


  23. SUKER M, Groot Koerkamp B, Nuyttens JJ, Dwarkasing RS, et al
    The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
    J Surg Oncol. 2020;122:450-456.
    PubMed     Abstract available


    August 2020
  24. KORYLLOS A, Lopez-Pastorini A, Zalepugas D, Galetin T, et al
    Optimal timing of surgery for bronchial sleeve resection after neoadjuvant chemoradiotherapy.
    J Surg Oncol. 2020;122:328-335.
    PubMed     Abstract available


  25. MINAMI K, Jimbo N, Tanaka Y, Ogawa H, et al
    Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    J Surg Oncol. 2020;122:243-253.
    PubMed     Abstract available


    June 2020
  26. BAUMANN BC, Bernstein KA, DeLaney TF, Simone CB, et al
    Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
    J Surg Oncol. 2020 Jun 25. doi: 10.1002/jso.26078.
    PubMed     Abstract available


  27. KAPETANAKIS EI, Filippiadis DK, Tomos IP, Karakatsani A, et al
    The role of percutaneous interventions in the management of lung cancer patients during the Covid-19 pandemic.
    J Surg Oncol. 2020 Jun 25. doi: 10.1002/jso.26084.
    PubMed    


  28. LI F, Zhao Y, Yuan L, Wang S, et al
    Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (
    J Surg Oncol. 2020;121:1132-1139.
    PubMed     Abstract available


  29. CHEN D, Wu X, Wen J, Xue Y, et al
    Comparison of sublobar resection and lobectomy for patients with small (
    J Surg Oncol. 2020 Jun 1. doi: 10.1002/jso.26051.
    PubMed     Abstract available


  30. GILL RR, Barlow J, Jaklitsch MT, Schmidlin EJ, et al
    Image-guided video-assisted thoracoscopic resection (iVATS): Translation to clinical practice-real-world experience.
    J Surg Oncol. 2020;121:1225-1232.
    PubMed     Abstract available


    May 2020
  31. KAPETANAKIS EI, Tomos IP, Karakatsani A, Koumarianou A, et al
    Management of surgical lung cancer patients during the COVID-19 pandemic in the financially and resource strained Greek health care system.
    J Surg Oncol. 2020 May 23. doi: 10.1002/jso.25988.
    PubMed    


  32. XU E, David EA, Ding L, Atay SM, et al
    Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer.
    J Surg Oncol. 2020 May 20. doi: 10.1002/jso.25937.
    PubMed     Abstract available


  33. MEHTA R, Tsilimigras DI, Paredes AZ, Sahara K, et al
    Comparing textbook outcomes among patients undergoing surgery for cancer at U. S. News & World Report ranked hospitals.
    J Surg Oncol. 2020;121:927-935.
    PubMed     Abstract available


  34. LI H, Wang Z, Yang F, Wang J, et al
    Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    J Surg Oncol. 2020;121:1027-1035.
    PubMed     Abstract available


    April 2020
  35. SHEWALE JB, Corsini EM, Correa AM, Brown EL, et al
    Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.
    J Surg Oncol. 2020 Apr 30. doi: 10.1002/jso.25966.
    PubMed     Abstract available


    March 2020
  36. SHI S, Xie H, Yin W, Zhang Y, et al
    The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
    J Surg Oncol. 2020 Mar 14. doi: 10.1002/jso.25903.
    PubMed     Abstract available


  37. CROWN A, Rocha FG, Raghu P, Lin B, et al
    Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    J Surg Oncol. 2020;121:480-485.
    PubMed     Abstract available


    February 2020
  38. CORSINI EM, Datar SS, Mitchell KG, Zhou N, et al
    High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
    J Surg Oncol. 2020 Feb 19. doi: 10.1002/jso.25871.
    PubMed     Abstract available


    October 2019
  39. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Abstract available


  40. YIN J, Zhao M, Lu T, Huang Y, et al
    Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer </=2 cm: A propensity score analysis.
    J Surg Oncol. 2019 Oct 10. doi: 10.1002/jso.25724.
    PubMed     Abstract available


    September 2019
  41. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Abstract available


  42. LONDERO F, Morelli A, Parise O, Grossi W, et al
    Lymphadenectomy during pulmonary metastasectomy: Impact on survival and recurrence.
    J Surg Oncol. 2019;120:768-778.
    PubMed     Abstract available


    August 2019
  43. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.
    PubMed    


  44. NEVALA R, Jaamaa S, Tukiainen E, Tarkkanen M, et al
    Long-term results of surgical resection of lung metastases from soft tissue sarcoma: A single center experience.
    J Surg Oncol. 2019;120:168-175.
    PubMed     Abstract available


    July 2019
  45. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Abstract available


    June 2019
  46. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Abstract available


    April 2019
  47. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Abstract available


    February 2019
  48. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Abstract available


  49. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Abstract available


    December 2018
  50. YUAN C, Tao X, Zheng D, Pan Y, et al
    The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    J Surg Oncol. 2018 Dec 9. doi: 10.1002/jso.25308.
    PubMed     Abstract available


  51. KADEER X, Wang L, Zhang L, Shi W, et al
    Modified hook-wire placement technique for localizing multiple pulmonary nodules.
    J Surg Oncol. 2018;118:1188-1193.
    PubMed     Abstract available


    November 2018
  52. VITI A, Socci L, Congregado M, Ismail M, et al
    The everlasting issue of prolonged air leaks after lobectomy for non-small cell lung cancer: A data-driven prevention planning model in the era of minimally invasive approaches.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25289.
    PubMed     Abstract available


    October 2018
  53. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Abstract available


    September 2018
  54. GILL RR, Murphy DJ, Kravets S, Sholl LM, et al
    Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25241.
    PubMed     Abstract available


  55. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Abstract available


  56. QUERO-VALENZUELA F, Piedra-Fernandez I, Hernandez-Escobar F
    Readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25207.
    PubMed    


    August 2018
  57. NEWTON AD, Predina JD, Nie S, Low PS, et al
    Intraoperative fluorescence imaging in thoracic surgery.
    J Surg Oncol. 2018;118:344-355.
    PubMed     Abstract available


    June 2018
  58. IMANISHI N, Hirai A, Yoneda K, Shimajiri S, et al
    Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung.
    J Surg Oncol. 2018;117:1563-1569.
    PubMed     Abstract available


  59. STILES ZE, Dickson PV, Glazer ES, Murphy AJ, et al
    Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma.
    J Surg Oncol. 2018;117:1759-1767.
    PubMed     Abstract available


    May 2018
  60. SAMBRI A, Bianchi G, Cevolani L, Donati D, et al
    Can radical margins improve prognosis in primary and localized epithelioid sarcoma of the extremities?
    J Surg Oncol. 2018;117:1204-1210.
    PubMed     Abstract available


    April 2018
  61. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Abstract available


  62. KAAKI S, Kidane B, Srinathan S, Tan L, et al
    Is tissue still the issue? Lobectomy for suspicious lung nodules without confirmation of malignancy.
    J Surg Oncol. 2018;117:977-984.
    PubMed     Abstract available


    March 2018
  63. COLLAUD S, Provost B, Besse B, Fabre D, et al
    Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    J Surg Oncol. 2018 Mar 24. doi: 10.1002/jso.25042.
    PubMed     Abstract available


  64. SON BY, Cho S, Yum SW, Kim K, et al
    The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
    J Surg Oncol. 2018;117:451-456.
    PubMed     Abstract available


  65. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Abstract available


    February 2018
  66. YU WS, Lee CY, Park SY, Suh JW, et al
    Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus.
    J Surg Oncol. 2018 Feb 6. doi: 10.1002/jso.24989.
    PubMed     Abstract available


  67. VODICKA J, Mukensnabl P, Vejvodova S, Spidlen V, et al
    A more sensitive detection of micrometastases of NSCLC in lymph nodes using the one-step nucleic acid amplification (OSNA) method.
    J Surg Oncol. 2018;117:163-170.
    PubMed     Abstract available


    January 2018
  68. QUERO-VALENZUELA F, Piedra-Fernandez I, Martinez-Ceres M, Romero-Palacios PJ, et al
    Predictors for 30-day readmission after pulmonary resection for lung cancer.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24973.
    PubMed     Abstract available


    December 2017
  69. SMITHY JW, Rosen JE, Gao SJ, Kim AW, et al
    Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    J Surg Oncol. 2017;116:1193-1196.
    PubMed     Abstract available


    November 2017
  70. KAPETANAKIS EI, Sidiropoulou T, Koumarianou A, Kostopanagiotou K, et al
    Delivering quality lung cancer care in crisis-wracked Greece.
    J Surg Oncol. 2017 Nov 22. doi: 10.1002/jso.24874.
    PubMed    


  71. SHE Y, Zhao L, Dai C, Ren Y, et al
    Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
    J Surg Oncol. 2017;116:756-762.
    PubMed     Abstract available


    October 2017
  72. APRILE V, Bertoglio P, Dini P, Palmiero G, et al
    Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy.
    J Surg Oncol. 2017 Oct 19. doi: 10.1002/jso.24884.
    PubMed     Abstract available


    September 2017
  73. MARULLI G, Rendina EA, Klepetko W, Perkmann R, et al
    Surgery for T4 lung cancer invading the thoracic aorta: Do we push the limits?
    J Surg Oncol. 2017 Sep 18. doi: 10.1002/jso.24784.
    PubMed     Abstract available


    August 2017
  74. WASEDA R, Klikovits T, Hoda MA, Hoetzenecker K, et al
    Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
    J Surg Oncol. 2017;116:227-235.
    PubMed     Abstract available


    June 2017
  75. TAIOLI E, Liu B, Nicastri DG, Lieberman-Cribbin W, et al
    Personal and hospital factors associated with limited surgical resection for lung cancer, in-hospital mortality and complications in New York State.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24697.
    PubMed     Abstract available


    May 2017
  76. YANG X, Sun F, Chen L, Shi M, et al
    Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24677.
    PubMed     Abstract available


    April 2017
  77. MCINTYRE A, Ganti AK
    Lung cancer-A global perspective.
    J Surg Oncol. 2017 Apr 18. doi: 10.1002/jso.24532.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: